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Significant left main coronary artery (LMCA) stenosis is not rare and reported 3 to 10% of patients undergoing
coronary angiography. Unprotected LMCA intervention is a still clinical challenge and surgery is still going to be a
traditional management method in many cardiac centers. With a presentation of drug eluting stent (DES), extensive use
of IVUS and skilled operators, number of such interventions increased rapidly which lead to change in
recommendation in the guidelines regarding LMCA procedures in the stable angina (Class 2a recommendation for
ostial and shaft lesion and class 2b recommendation for distal bifurcation lesion). However, there was not clear
consensus about the management of unprotected LMCA lesion associated with acute myocardial infarction (MI) with a
LMCA culprit lesion itself or distinct culprit lesion of other major coronary arteries. Surgery could be preferred as an
obligatory management strategy even in the high risk patients. With this review, we aimed to demonstrate treatment
strategies of LMCA disease associated with acute coronary syndrome, particularly acute myocardial infarction (MI). In
addition, we presented a short case series with LMCA lesion and ST elevated acute MI in which culprit lesion placed
either in the left anterior descending artery or circumflex artery. We reviewed the current medical literature and propose
simple algorithm for management.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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CABG coronary artery bypass graft
CX circumflex artery
DES drug-eluting stent
IVUS intravascular ultrasonography
LAD left anterior descending artery
LMCA left main coronary artery MI
myocardial infarction
PCI percutaneous coronary interventions
RCA right coronary artery
SYNTAX synergy between percutaneous coronary inter-
vention with TAXUS and cardiac surgery
TIMI thrombolysis in myocardial infarctionIntroduction
Significant left main coronary artery (LMCA)stenosis is not rare, occurring among a
reported 3% to 10% of patients undergoing coro-
nary angiography [1]. Unprotected LMCA inter-
vention remains a clinical challenge. With the
advent of drug-eluting stent (DES), extensive use
of IVUS and skilled operators, the number of such
interventions have increased rapidly, leading
to changes in guideline recommendations for
LMCA procedures in stable angina (Class 2a rec-
ommendation for ostial and shaft lesions and class
2b recommendation for distal bifurcation lesions)
[2]. Moreover, isolated LMCA disease with low
SYNTAX score (622) was recommended as class
1 indication with the level of evidence of B in the
recent revascularization guidelines of European
Society of Cardiology. However, there was no
clear consensus on unprotected LMCA lesions
associated with acute myocardial infarction with
culprit lesion of LMCA itself or distinct culprit
lesion of other major coronary arteries [3–6].
This review sought to demonstrate the treat-
ment strategies of LMCA disease associated with
acute coronary syndromes, particularly acute
myocardial infarction (MI). In addition, we pre-
sent a short case series with an LMCA lesion
and ST-elevated acute MI in which the culprit
lesion was placed either in the left anterior
descending artery (LAD) or circumflex artery
(CX). We review the current medical literature1. Indication for coronary bypass graft surgery vs. percutan
s suitable for both procedures.
CA LES_ION Fav
ft main with SYNTAX score 622 1 (L
ft main with SYNTAX score 23–32 1 (L
ft main with SYNTAX score >32 1 (L
ft main (isolated or 1 VD, ostium/shaft) 1 (L
ft main (isolated or 1 VD, distal bifurcation) 1 (L
ft main + 2 VD or 3 VD, SYNTAX score 632 1 (L
ft main + 2 VD or 3 VD, SYNTAX score P33 1 (L
, Left main coronary artery; CABG, Coronary artery bypass graft; PCI,
aneous coronary intervention with taxus and cardiac surgery.
ording to 2014 European Society of Cardiology Guidelines in Myocar
ording to 2010 European Society of Cardiology Guidelines in Myocarand conclude with an algorithm for LMCA lesions
associated with acute coronary syndromes.Current management of left main coronary
artery stenosis in stable angina
Surgery is accepted as a traditional and stan-
dard treatment of unprotected LMCA disease.
Recent data comparing the safety and efficacy of
LMCA interventions with DES and coronary
artery bypass graft (CABG) surgery showed com-
parable results in terms of safety and mortality
[2]. Long-term mortality rates were also similar.
However, percutaneous coronary interventions
(PCI) were associated with higher rates of repeat
revascularization, whereas CABG was associated
with higher stroke rate compared to PCI [7–10].
Patient selection for both strategies is fundamentaleous coronary intervention in the stable angina patients with
ours CABG Favours PCI
evel of evidence – B) 1 Level of evidence – B)
evel of evidence – B) 2a (Level of evidence – B)
evel of evidence – B) 3 (Level of evidence – B)
evel of evidence – A) 2a (Level of evidence – B)
evel of evidence – A) 2b (Level of evidence – B)
evel of evidence – A) 2b (Level of evidence – B)
evel of evidence – A) 3 (Level of evidence – B)
Percutaneous coronary; VD, Vessel disease; SYNTAX, Synergy between
dial Revascularisation.
dial Revascularisation.
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2015;27:272–276and may directly impact clinical outcome. For this
reason, LMCA disease management should be dis-
cussed extensively by the heart team prior to treat-
ment. LMCA lesion >50% with documented
ischemia or fractional flow reserve <0.80 for angio-
graphic diameter stenosis between 50% and 70%
and more than 70% stenosis of LMCA lesion should
be revascularized for prognosis and improved sur-
vival. The current guidelines of the European
Society of Cardiology on LMCA disease manage-
ment in stable angina are summarized in Table 1 [11].Left main coronary artery stenosis as a culprit
lesion in the acute coronary syndromes
In patients with LMCA culprit lesions, the opti-
mal revascularization strategy is not obvious [3–6].
Most patients usually present with hemodynamic
instability and cardiogenic shock. Even after suc-
cessful revascularization, the mortality rate is
higher when compared to stable patients [12,13].
Treatment allocation is primarily determined by
presentation with thrombolysis in myocardial
infarction (TIMI) 0/1 flow. As percutaneous inter-
vention offers an earlier restoration of TIMI flow,
PCI could be the obligatory treatment strategy
[14–16]. In the case of hemodynamic stability,
treatment approach could either be PCI or surgery
in parallel with guidelines for stable patients [4].
Multi-vessel disease with higher SYNTAX score
(P33) could be a major candidate for bypass sur-
gery [17,18], whereas higher operative risk
assessed by euroSCORE and higher possibility
of complete revascularization may require PCI
[19] The following clinical variables were shown
as prognostic factors in a LMCA culprit lesion:
– Cardiogenic shock: a strong indicator of mortal-
ity [20], and associated with nearly fourfold
increment in 30-day mortality (55% vs 15% in
non-cardiogenic shock patients) [20]
– ST-elevation MI is associated with higher
periprocedural complications and higher six-
month mortality compared to non-ST-elevation
MI and unstable angina patients [1]
– Initial TIMI 1/0 flow
– Reduced left ventricular ejection fraction
– Older age
– Multi-vessel disease and high SYNTAX score
– Diabetes mellitus.
Cardiogenic shock with isolated LMCA culprit
lesion shows relatively better prognosis after suc-
cessful primary PCI compared to multi-vessel dis-
ease. Such patients usually recover earlier from
cardiogenic shock; and long-term prognosis issimilar to non-cardiogenic shock patients in
selected patient groups [21]. PCI should be pre-
ferred in the presence of the following clinical
features:
– Cardiogenic shock
– Initial TIMI 1/0 flow
– Isolated LMCA culprit lesion
– Poor surgical candidate (high euroSCORE, dis-
tal coronary disease unfavorable to CABG or
co-morbidity, including chronic obstructive
lung disease and renal failure)
– Favorable anatomy providing complete revas-
cularization (low or intermediate SYNTAX
score)
– Patients with rudimentary circumflex artery
– Advanced age (octogenarians).
In the following clinical settings with hemo-
dynamic stability and low perioperative risk,
CABG is a preferred option:
– Concomitant valvular disease or mechanical
complication
– Heavy calcified LMCA disease
– Multi-vessel disease with high SYNTAX score
– Reduced left ventricular function
– Diabetic patients.
Left main coronary artery stenosis as a non-
culprit lesion in acute coronary syndromes
Concurrent LMCA and non-LMCA PCI has
worse outcomes than isolated LMCA PCI [14].
Thus, it is logical to postpone LMCA revascular-
ization if the culprit lesion is located in the right
coronary artery (RCA). However, PCI of culprit
lesion located either in LAD or CX in the presence
of significant LMCA lesion is a hazardous clinical
issue and may necessitate concurrent LMCA
intervention. Short and long-term data on simul-
taneous PCI of LMCA and non-LMCA culprit ves-
sel are not well-defined.
Short case series
Herein we describe our short case series and
discuss treatment strategies. The cases described
here were collected at the International Medicine
Hospital of Kosovo. We performed 10 cases of
ST-elevated MI with significant LMCA stenosis.
Among them, five culprit lesions were located in
LAD, two in CX and three in the RCA. We did
not perform LMCA interventions with a culprit
lesion of RCA in the same session. We initially
performed three primary PCIs of RCAs, and we
postponed LMCA interventions for elective
Figure 1. A systematic algorithm for LMCA disease in patients with acute coronary syndrome.
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MANAGEMENT OF LMCA DISEASE IN MYOCARDIAL INFARCTIONprocedures. In patients with culprit lesions located
in the left coronary system, our primary goal was
to open culprit lesions initially and then after
myocardial salvation; and finally to perform
LMCA intervention. In one patient with LAD
lesion, LMCA stenosis was over the 95% which
necessitated initial LMCA intervention. In all pro-
cedures, we used DES and LMCA intervention
performed without IVUS support. We could not
use IVUS due to affordability. Only one case per-
tained to distal LMCA bifurcation lesion; the rest
were either ostial or shaft lesions. The mean
euroSCORE value was 13.0. All patients were
discharged without in-hospital complications,
and control examinations at six months were
uneventful.
This short series may indicate the feasibility of
concurrent LMCA and non-LMCA culprit vessel
interventions in selected patients. In the presence
of the following clinical features, PCI may be the
preferred option:
– Cardiogenic shock
– Critical LMCA stenosis which complicates
secure PCI of culprit lesion placed either in
LAD or CX
– Isolated LMCA ostial and/or shaft lesion accom-
pany culprit lesion.
– Elderly with favorable anatomy providing com-
plete revascularization if elective procedure is
not possible (patient demands)
In stable patients with moderately stenotic
distal LMCA lesion, target vessels should berevascularized initially, and elective LMCA
assessment and intervention should be scheduled
after a certain period of time. A systematic algo-
rithm for LMCA disease in patients with acute
coronary syndrome is summarized in Fig. 1.Conclusion
In the setting of acute coronary syndromes, per-
cutaneous intervention of unprotected LMCA
lesions can be performed with reliable results in
selected patients. Cardiogenic shock and hemody-
namic instability are obligatory indications for
PCI, although associated major adverse cardiac
events are more frequent. Surgery can be selected
for stable patients with multi-vessel diseases and/
or higher SYNTAX score. Concurrent LMCA and
non-LMCA culprit vessel intervention can also
be performed securely with good long-term
results in selected patients.Acknowledgements
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